TY - JOUR
T1 - Prior treatment received by patients with bulimia nervosa
AU - Crow, Scott
AU - Mussell, Melissa Pederson
AU - Peterson, Carol
AU - Knopke, Amy
AU - Mitchell, James
PY - 1999/1
Y1 - 1999/1
N2 - Objective: This study examined the frequency with which subjects with bulimia nervosa (BN) presenting for treatment or follow-up studies had previously received either adequate pharmacologic treatment or cognitive- behavioral therapy (CBT). Method: Semi-structured telephone screening of individuals who called in response to advertisements about research studies was used to establish diagnoses and to clarify prior pharmacologic and psychotherapeutic treatments for BN. Results: Of 581 women responding, 353 (60.8%) had probable BN. Overall, 61.4% of these subjects had received psychotherapy (96.7%) but rarely CBT (6.9%). Over one haft (63.7%) had received pharmacologic treatment, most commonly with fluoxetine (72.5%). Of those having received any medication treatment, 46,2% were judged to have received at least one adequate trial. Overall, 35.0% of those previously treated had received at least one prior course of adequate pharmacotherapy or CBT for BN. Conclusion: Although efficacious treatments for BN have been established, they have not been received by most individuals presenting for further treatment.
AB - Objective: This study examined the frequency with which subjects with bulimia nervosa (BN) presenting for treatment or follow-up studies had previously received either adequate pharmacologic treatment or cognitive- behavioral therapy (CBT). Method: Semi-structured telephone screening of individuals who called in response to advertisements about research studies was used to establish diagnoses and to clarify prior pharmacologic and psychotherapeutic treatments for BN. Results: Of 581 women responding, 353 (60.8%) had probable BN. Overall, 61.4% of these subjects had received psychotherapy (96.7%) but rarely CBT (6.9%). Over one haft (63.7%) had received pharmacologic treatment, most commonly with fluoxetine (72.5%). Of those having received any medication treatment, 46,2% were judged to have received at least one adequate trial. Overall, 35.0% of those previously treated had received at least one prior course of adequate pharmacotherapy or CBT for BN. Conclusion: Although efficacious treatments for BN have been established, they have not been received by most individuals presenting for further treatment.
KW - Bulimia nervosa
KW - Cognitive behavioral therapy
KW - Pharmacologic treatment
UR - http://www.scopus.com/inward/record.url?scp=0032943852&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032943852&partnerID=8YFLogxK
U2 - 10.1002/(SICI)1098-108X(199901)25:1<39::AID-EAT5>3.0.CO;2-W
DO - 10.1002/(SICI)1098-108X(199901)25:1<39::AID-EAT5>3.0.CO;2-W
M3 - Article
C2 - 9924651
AN - SCOPUS:0032943852
SN - 0276-3478
VL - 25
SP - 39
EP - 44
JO - International Journal of Eating Disorders
JF - International Journal of Eating Disorders
IS - 1
ER -